Literature DB >> 2575325

Two binding sites for Ki67 related to quiescent and cycling cells in human epidermis.

J J Rijzewijk1, P E Van Erp, F W Bauer.   

Abstract

The monoclonal antibody Ki67 (Ki67) binds to a nuclear antigen expressed by cycling cells of several human tissues and to the cytoplasm of the basal layer cells of squamous epithelia. We have used an immunohistochemical method to visualize the binding sites of Ki67 in normal and hyperproliferative epidermis. Cytoplasmic staining was present in the basal layer cells of normal epidermis, but was decreased in psoriatic and post-tapestripping epidermis. In sections of normal epidermis only a small minority of nuclei were positive, but sections of psoriatic epidermis and epidermis 40 and 48 h after tapestripping showed large numbers of positive nuclei in the basal and suprabasal layers. Since recent reports strongly suggest that the cell production rate is regulated by changes in the number of cycling cells, the hypothesis that Ki67 binds also in human epidermis to the nuclei of cycling cells is supported by the present findings.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2575325

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  9 in total

1.  Repeated tape stripping of normal skin: a histological assessment and comparison with events seen in psoriasis.

Authors:  M J Gerritsen; P E van Erp; I M van Vlijmen-Willems; L T Lenders; P C van de Kerkhof
Journal:  Arch Dermatol Res       Date:  1994       Impact factor: 3.017

2.  Multiparameter flow cytometric characterization of epidermal cell suspensions prepared from normal and hyperproliferative human skin using an optimized thermolysin-trypsin protocol.

Authors:  C P Glade; B A Seegers; E F Meulen; C A van Hooijdonk; P E van Erp; P C van de Kerkhof
Journal:  Arch Dermatol Res       Date:  1996-04       Impact factor: 3.017

3.  The immunohistochemical effects of a single challenge with an intermediate dose of ultraviolet B on normal human skin.

Authors:  C J van der Vleuten; E J Kroot; E M de Jong; P C van de Kerkhof
Journal:  Arch Dermatol Res       Date:  1996-08       Impact factor: 3.017

4.  The growth and differentiation of human keratinocytes in vitro: a combined immunohistochemical and flow cytometric study.

Authors:  P E van Erp; G J de Jongh; J B Boezeman; J Schalkwijk
Journal:  Arch Dermatol Res       Date:  1994       Impact factor: 3.017

5.  Loss of tumor progression locus 2 (tpl2) enhances tumorigenesis and inflammation in two-stage skin carcinogenesis.

Authors:  K L Decicco-Skinner; E L Trovato; J K Simmons; P K Lepage; J S Wiest
Journal:  Oncogene       Date:  2010-10-11       Impact factor: 9.867

6.  Role of the Cldn6 cytoplasmic tail domain in membrane targeting and epidermal differentiation in vivo.

Authors:  Azadeh Arabzadeh; Tammy-Claire Troy; Kursad Turksen
Journal:  Mol Cell Biol       Date:  2006-08       Impact factor: 4.272

7.  Noninvasive Tape-Stripping with High-Resolution RNA Profiling Effectively Captures a Preinflammatory State in Nonlesional Psoriatic Skin.

Authors:  Lam C Tsoi; Xianying Xing; Enze Xing; Rachael Wasikowski; Shuai Shao; Chang Zeng; Olesya Plazyo; Joseph Kirma; Yanyung Jiang; Allison C Billi; Mrinal K Sarkar; Jessica L Turnier; Ranjitha Uppala; Kathleen M Smith; Yolanda Helfrich; John J Voorhees; Emanual Maverakis; Robert L Modlin; J Michelle Kahlenberg; Victoria E Scott; Johann E Gudjonsson
Journal:  J Invest Dermatol       Date:  2021-11-19       Impact factor: 7.590

8.  Epidermal growth in the skin equivalent.

Authors:  J Fransson; H Hammar
Journal:  Arch Dermatol Res       Date:  1992       Impact factor: 3.017

9.  Atrial natriuretic peptide type C induces a cell-cycle switch from proliferation to differentiation in brain-derived neurotrophic factor- or nerve growth factor-primed olfactory receptor neurons.

Authors:  P Jeanette Simpson; Ian Miller; Cheil Moon; Andrea L Hanlon; Daniel J Liebl; Gabriele V Ronnett
Journal:  J Neurosci       Date:  2002-07-01       Impact factor: 6.167

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.